ivabradine has been researched along with Day Blindness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riccioni, G | 1 |
| Borer, JS; Fox, K; Jaillon, P; Lerebours, G | 1 |
1 review(s) available for ivabradine and Day Blindness
| Article | Year |
|---|---|
Focus on ivabradine: a new heart rate-controlling drug.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Heart Rate; Humans; Ivabradine; Risk Factors; Vision Disorders | 2009 |
1 trial(s) available for ivabradine and Day Blindness
| Article | Year |
|---|---|
Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzazepines; Depression, Chemical; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Sinoatrial Node; Treatment Outcome; Vision Disorders | 2003 |